SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.

Clicks: 261
ID: 34509
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #181 of 485 articles by views in Nature communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 485 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b) is a lipid raft enzyme that regulates plasma membrane (PM) fluidity. Here we report that SMPDL3b excess, as observed in podocytes in diabetic kidney disease (DKD), impairs insulin receptor isoform B-dependent pro-survival insulin signaling by interfering with insulin receptor isoforms binding to caveolin-1 in the PM. SMPDL3b excess affects the production of active sphingolipids resulting in decreased ceramide-1-phosphate (C1P) content as observed in human podocytes in vitro and in kidney cortexes of diabetic db/db mice in vivo. Podocyte-specific Smpdl3b deficiency in db/db mice is sufficient to restore kidney cortex C1P content and to protect from DKD. Exogenous administration of C1P restores IR signaling in vitro and prevents established DKD progression in vivo. Taken together, we identify SMPDL3b as a modulator of insulin signaling and demonstrate that supplementation with exogenous C1P may represent a lipid therapeutic strategy to treat diabetic complications such as DKD.
Reference Key
mitrofanova2019smpdl3bnature Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mitrofanova, A;Mallela, S K;Ducasa, G M;Yoo, T H;Rosenfeld-Gur, E;Zelnik, I D;Molina, J;Varona Santos, J;Ge, M;Sloan, A;Kim, J J;Pedigo, C;Bryn, J;Volosenco, I;Faul, C;Zeidan, Y H;Garcia Hernandez, C;Mendez, A J;Leibiger, I;Burke, G W;Futerman, A H;Barisoni, L;Ishimoto, Y;Inagi, R;Merscher, S;Fornoni, A;
Journal Nature communications
Year 2019
DOI
10.1038/s41467-019-10584-4
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.